UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2001, ISBN 185317890X, xv, 528
Book
2008, ISBN 3540723021, x, 294
Book
The New England journal of medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 12, pp. 1136 - 1152
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prognosis | Cytarabine - therapeutic use | Humans | Hematopoietic Stem Cell Transplantation | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Signal Transduction - genetics | Mutation | Remission Induction | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Monoclonal antibodies | Dosage and administration | Myeloid leukemia | Medical prognosis | Leukemia | Classification | Bone marrow | Genomes | Acute myeloid leukemia | Patients | Cancer therapies | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
2007, Contemporary hematology, ISBN 9781588296214, xiv, 426 p., [8] p. of plates
Book
The Lancet (British edition), ISSN 0140-6736, 08/2018, Volume 392, Issue 10147, pp. 593 - 606
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Assessment | Genomics | Humans | Risk Factors | Hematopoietic Stem Cell Transplantation | Staurosporine - analogs & derivatives | Antineoplastic Agents - therapeutic use | Consolidation Chemotherapy | Remission Induction | Cytarabine - administration & dosage | Patient Selection | Leukemia, Myeloid, Acute - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Staurosporine - therapeutic use | Leukemia, Myeloid, Acute - drug therapy | Leukemia, Myeloid, Acute - therapy | Aminoglycosides - therapeutic use | Leukemia, Myeloid, Acute - genetics | Strategic planning (Business) | Drug approval | Drugs | Pathogenesis | Leukemia | Clinical trials | Cytotoxicity | Genomes | Drug development | Regulatory approval | Older people | Risk assessment | Bone marrow | Drug dosages | Age | Medical research | Hematology | Cloning | Health risks | FDA approval | Patients | Chemotherapy | Medical prognosis | Response rates | Stem cells | Mutation | Risk management | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2010, Volume 115, Issue 10, pp. 1976 - 1984
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Immunotherapy, Adoptive - methods | Antigens, CD34 - metabolism | Erythroid Precursor Cells - transplantation | Leukemia, Myeloid, Acute - pathology | Humans | Leukemia, Myeloid, Acute - metabolism | Mutant Proteins - metabolism | Nuclear Proteins - metabolism | Cell Separation - methods | Mice, SCID | Mice, Knockout | Xenograft Model Antitumor Assays | Erythroid Precursor Cells - pathology | Phenotype | Animals | Neoplastic Stem Cells - metabolism | Erythroid Precursor Cells - metabolism | Neoplastic Stem Cells - pathology | ADP-ribosyl Cyclase 1 - metabolism | Mice, Inbred NOD | Mice | Nuclear Proteins - genetics | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus | Myeloid Neoplasia
Journal Article
7.
Full Text
MLL-AF9-and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C
The Journal of clinical investigation, ISSN 0021-9738, 03/2016, Volume 126, Issue 3, pp. 997 - 1011
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neoplasm Transplantation | Gene Expression | Leukemia, Myeloid, Acute - pathology | Leukemia, Myeloid, Acute - metabolism | Jumonji Domain-Containing Histone Demethylases - physiology | Mice, Knockout | Oncogene Proteins, Fusion - physiology | Cell Self Renewal | Animals | Hematopoietic Stem Cells - physiology | Tumor Cells, Cultured | Homeodomain Proteins - physiology | Neoplastic Stem Cells - physiology | Leukemia, Myeloid, Acute - genetics | Health aspects | Analysis | Hematopoietic stem cells | Cellular proteins | Genetic aspects | Gene expression | Proteins | Data analysis | Leukemia | Rodents | Medical prognosis | Stem cells | Epigenetics | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
8.
Full Text
CD34(+)CD38(-) leukemic stem cell frequency to predict outcome in acute myeloid leukemia
Leukemia, ISSN 0887-6924, 2019, Volume 33, Issue 5, pp. 1102 - 1112
Journal Article
British journal of haematology, ISSN 0007-1048, 01/2008, Volume 140, Issue 2, pp. 123 - 132
familial | CEBPA | myelodysplasia | acute myeloid leukaemia | RUNX1 | Acute myeloid leukaemia | Myelodysplasia | Familial | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Genetic Predisposition to Disease | Pedigree | Humans | Germ-Line Mutation | Myelodysplastic Syndromes - genetics | Neoplastic Syndromes, Hereditary - genetics | CCAAT-Enhancer-Binding Proteins - genetics | Core Binding Factor Alpha 2 Subunit - genetics | Leukemia, Myeloid, Acute - genetics | Genetic aspects | Tissue specific antigens | Index Medicus
Journal Article